Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-18 Sale | 2024-01-18 8:22 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P Chief Executive Officer | 14,580 | $1.1906 | $17,359 | 57,112 (Direct) | View |
| 2023-05-19 Sale | 2023-05-23 5:18 pm | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 272 | $10.58 | $2,878 | 11,961 (Direct) | View |
| 2022-01-26 Purchase | 2022-01-26 4:13 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 100,000 | $0.2152 | $21,520 | 2,017,006 (Direct) | View |
| 2022-01-03 Sale | 2022-01-04 4:17 pm | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 40,000 | $22.59 | $903,650 | 13,500 (Direct) | View |
| 2021-05-17 Sale | 2021-05-17 7:13 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,186 | $0.89 | $3,726 | 316,292 (Direct) | View |
| 2021-02-16 Sale(A) | 2021-04-16 4:11 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,144 | $1.72 | $7,128 | 244,628 (Direct) | View |
| 2021-02-16 Sale | 2021-02-17 5:23 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,144 | $1.72 | $7,128 | 485,756 (Direct) | View |
| 2020-11-16 Sale | 2020-11-18 4:09 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 6,094 | $0.5211 | $3,176 | 215,994 (Direct) | View |
| 2020-08-14 Sale | 2020-08-17 8:22 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,245 | $0.6049 | $2,568 | 222,088 (Direct) | View |
| 2020-05-15 Sale | 2020-05-18 4:28 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,426 | $0.6267 | $2,774 | 226,333 (Direct) | View |
| 2020-02-18 Sale | 2020-02-19 6:09 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,324 | $0.8304 | $3,591 | 230,759 (Direct) | View |
| 2020-01-02 Sale | 2020-01-03 4:07 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 8,345 | $0.9667 | $8,067 | 235,083 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-20 Option Award | 2024-05-21 4:21 pm | N/A 2034-05-19 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P Chief Executive Officer | 990,000 | $0 | 990,000 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 5:16 pm | N/A 2034-01-11 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P Chief Executive Officer | 279,000 | $0 | 320,692 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:17 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 1,312,500 | $0 | 1,312,500 (Direct) | View |
| 2023-05-18 Exercise | 2023-05-23 5:18 pm | 2023-05-18 N/A | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 8,733 | $0 | 11,961 (Direct) | View |
| 2023-01-11 Option Award | 2023-01-17 4:11 pm | N/A 2033-01-10 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-05-18 Option Award | 2022-05-20 4:07 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 23,345 | $0 | 23,345 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-11 4:54 pm | N/A 2030-01-20 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-26 4:13 pm | N/A 2032-01-11 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 1,600,000 | $0 | 2,017,006 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-04 4:17 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 40,000 | $5.08 | 13,500 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-04 4:17 pm | N/A 2028-02-08 | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 40,000 | $0 | 13,500 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-16 9:23 pm | N/A 2031-06-14 | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 31,347 | $0 | 31,347 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 8:31 pm | N/A 2031-06-09 | Zosano Pharma Corp | ZSAN | Hagan Joseph P Director | 45,000 | $0 | 52,500 (Direct) | View |
| 2021-04-14 Conversion | 2021-04-16 4:12 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 83,435 | $0 | 320,478 (Indirect) | View |
| 2021-02-04 Option Award | 2021-02-05 5:01 pm | N/A 2031-02-04 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 600,000 | $0 | 600,000 (Direct) | View |
Ownership | 2021-01-04 5:56 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 0 | $0 | 128,500 (Direct) | View |
| 2020-12-04 Option Award | 2020-12-07 4:22 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 29,760 | $0.125 | 255,434 (Indirect) | View |
| 2020-12-04 Option Award | 2020-12-07 4:22 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 39,680 | $0.6301 | 255,434 (Indirect) | View |
| 2020-06-25 Option Award | 2020-06-29 9:54 pm | N/A N/A | Zosano Pharma Corp | ZSAN | Hagan Joseph P Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:05 pm | N/A 2030-06-02 | Zosano Pharma Corp | ZSAN | Hagan Joseph P Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-01-22 Option Award | 2020-01-24 4:13 pm | N/A 2030-01-21 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 900,000 | $0 | 900,000 (Direct) | View |
| 2019-12-24 Option Award | 2019-12-26 08:50 am | N/A N/A | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 7,585 | $6.66 | 83,435 (Indirect) | View |
| 2019-12-24 Option Award | 2019-12-26 08:50 am | 2019-12-24 2024-12-24 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 75,850 | $0.125 | 83,435 (Indirect) | View |